Business Description
Getein Biotech Inc
ISIN : CNE100002RR9
Share Class Description:
SHSE:603387: Class ACompare
Compare
Traded in other countries / regions
603387.China IPO Date
2017-07-17Description
Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.45 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 2.29 | |||||
Interest Coverage | 17.45 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.07 | |||||
Beneish M-Score | -2.61 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.8 | |||||
3-Year EBITDA Growth Rate | -0.1 | |||||
3-Year EPS without NRI Growth Rate | -0.3 | |||||
3-Year FCF Growth Rate | 1.4 | |||||
3-Year Book Growth Rate | 11.9 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.77 | |||||
9-Day RSI | 35.18 | |||||
14-Day RSI | 39.82 | |||||
6-1 Month Momentum % | -19.57 | |||||
12-1 Month Momentum % | -34.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.22 | |||||
Quick Ratio | 1.97 | |||||
Cash Ratio | 1.03 | |||||
Days Inventory | 225.36 | |||||
Days Sales Outstanding | 128.2 | |||||
Days Payable | 100.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.66 | |||||
Dividend Payout Ratio | 0.76 | |||||
3-Year Dividend Growth Rate | 25.2 | |||||
Forward Dividend Yield % | 2.66 | |||||
5-Year Yield-on-Cost % | 9 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 0.9 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.18 | |||||
Operating Margin % | 18.27 | |||||
Net Margin % | 18.7 | |||||
FCF Margin % | 9.62 | |||||
ROE % | 9.53 | |||||
ROA % | 6.54 | |||||
ROIC % | 8.71 | |||||
ROC (Joel Greenblatt) % | 17.53 | |||||
ROCE % | 10.07 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.33 | |||||
Forward PE Ratio | 9.2 | |||||
PE Ratio without NRI | 13.91 | |||||
Shiller PE Ratio | 13.14 | |||||
Price-to-Owner-Earnings | 36.8 | |||||
PEG Ratio | 1.31 | |||||
PS Ratio | 2.87 | |||||
PB Ratio | 1.41 | |||||
Price-to-Tangible-Book | 1.53 | |||||
Price-to-Free-Cash-Flow | 29.92 | |||||
Price-to-Operating-Cash-Flow | 9.67 | |||||
EV-to-EBIT | 12.49 | |||||
EV-to-EBITDA | 12.49 | |||||
EV-to-Revenue | 2.69 | |||||
EV-to-FCF | 30.09 | |||||
Price-to-Projected-FCF | 0.94 | |||||
Price-to-Graham-Number | 0.97 | |||||
Price-to-Net-Current-Asset-Value | 4.25 | |||||
Earnings Yield (Greenblatt) % | 8.01 | |||||
FCF Yield % | 3.37 | |||||
Forward Rate of Return (Yacktman) % | 3.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Getein Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,306.429 | ||
EPS (TTM) (Â¥) | 0.48 | ||
Beta | 0.94 | ||
Volatility % | 27.27 | ||
14-Day RSI | 39.82 | ||
14-Day ATR (Â¥) | 0.258171 | ||
20-Day SMA (Â¥) | 7.704 | ||
12-1 Month Momentum % | -34.91 | ||
52-Week Range (Â¥) | 7.22 - 12.17 | ||
Shares Outstanding (Mil) | 507.15 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Getein Biotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Getein Biotech Inc Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Getein Biotech Inc Frequently Asked Questions
What is Getein Biotech Inc(SHSE:603387)'s stock price today?
The current price of SHSE:603387 is ¥7.36. The 52 week high of SHSE:603387 is ¥12.17 and 52 week low is ¥7.22.
When is next earnings date of Getein Biotech Inc(SHSE:603387)?
The next earnings date of Getein Biotech Inc(SHSE:603387) is .
Does Getein Biotech Inc(SHSE:603387) pay dividends? If so, how much?
The Dividend Yield %  of Getein Biotech Inc(SHSE:603387) is 2.66% (As of Today), Highest Dividend Payout Ratio of Getein Biotech Inc(SHSE:603387) was 0.83. The lowest was 0.26. And the median was 0.33. The  Forward Dividend Yield % of Getein Biotech Inc(SHSE:603387) is 2.66%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |